Literature DB >> 29995121

Comparison of the efficacy of 0.03% tacrolimus eye drops diluted in olive oil and linseed oil for the treatment of keratoconjunctivitis sicca in dogs.

Luís Felipe da Costa Zulim1, Gisele Alborgetti Nai2, Rogério Giuffrida1, Carolina Silva Guimarães Pereira1, Hugo Benguella3, Aline Gutierrez Cruz3, Bruna Toledo Duran Foglia3, Aline da Silveira Batista4, Silvia Franco Andrade1.   

Abstract

OBJECTIVE: To compare the efficacy of 0.03% tacrolimus eye drops diluted in two different vehicles (linseed oil and olive oil) for the treatment of keratoconjunctivitis sicca (KCS) in dogs.
METHODS: This study included 60 dogs. Of this group, 20 were healthy and allocated to the control group, and 40 were diagnosed with bilateral KCS and randomly allocated to either the TO (tacrolimus in olive oil) or the TL (tacrolimus in linseed oil) groups. Ophthalmic examinations, Schirmer Tear Test-1 (STT-1), Tear Film Break-up Time (TBUT) and Fluorescein Test (FT) were carried out monthly, along with cytological and histopathological examinations at the beginning and end of the study.
RESULTS: The clinical signs, corneal ulcers, Schirmer Tear Test-1 values, and Tear Film Break-up Time values improved in both groups after one month of treatment. Cytological examination at the end of the study showed decreased lymphocytes, neutrophil, metaplastic, and squamous cell counts in both groups, while the histopathological analysis showed decreases in lymphocytes and neutrophils and an increase in goblet cell density (cells/mm2). The decreases in neutrophil count were more significant (p<0.05) in the TL group for both types of examination.
CONCLUSION: In sum, 0.03% tacrolimus eye drops diluted in olive oil and linseed oil were effective in the treatment of keratoconjunctivitis sicca. None of the evaluated parameters differed significantly between the two groups, except for neutrophil count which was significantly lower in the TL group. Thus, linseed oil may be considered as an alternative diluent for tacrolimus eye drops.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29995121     DOI: 10.5935/0004-2749.20180059

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  4 in total

Review 1.  Emerging Therapeutics for Ocular Surface Disease.

Authors:  Leonard Bielory; Dovid Schoenberg
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

Review 2.  Ocular toxicity of mustard gas: A concise review.

Authors:  Allison Fuchs; Elizabeth A Giuliano; Nishant R Sinha; Rajiv R Mohan
Journal:  Toxicol Lett       Date:  2021-02-15       Impact factor: 4.271

Review 3.  Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials.

Authors:  Min Zhao; Fazhong He; Jianping Zhang; Zhiling Zhou; Yang Yang; Weijie Lin; Wentao Qiu; Qian Meng
Journal:  Eur J Hosp Pharm       Date:  2020-11-03

4.  Physicochemical Stability of a Novel Tacrolimus Ophthalmic Formulation for the Treatment of Ophthalmic Inflammatory Diseases.

Authors:  Marion Barrieu; Philip Chennell; Mouloud Yessaad; Yassine Bouattour; Mathieu Wasiak; Mireille Jouannet; Yoann Le Basle; Valérie Sautou
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.